Cocrystal Pharma Inc (COCP)

[cash_cow1]

Are big pharma waiting for Cocrystal Pharma inc to chose their leading compound to develop the drug to treat COVID-19. The company has the compound molecules to treat the infection cause by the corona virus in the respiratory system. The company has mention earlier this year they will be releasing the leading compound to treat coronavirus this year in the second quarter. We're now at the end of the second quarter. Now are other potential partners waiting for Cocrystal Pharma to produce the compounds it actually needs to produce the treatment for COVID-19. We all whom are heavy invested in Cocrystal Pharma inc stock is waiting for Dr Gary Wilcox and Kansas State University Research Foundation to make an announcement soon on the leading compound they will chose for the COVID-19 treatment. Cocrystal Pharma inc had many months to chose a leading compound. The investors and shareholders is growing impatient with the company in choosing a lead compound.